Fujian Cosunter Pharmaceutical Co., Ltd. — Investor Relations & Filings
Fujian Cosunter Pharmaceutical Co., Ltd. specializes in the research, development, production, and commercialization of pharmaceutical products. The company maintains a strong focus on antiviral therapies, particularly for the treatment of chronic Hepatitis B, with a product portfolio featuring Entecavir, Tenofovir Disoproxil Fumarate, and Adefovir Dipivoxil. Its therapeutic reach extends to cardiovascular, respiratory, and digestive system medications. The organization operates integrated manufacturing platforms and research centers dedicated to the innovation of small molecule drugs and high-end generic formulations. By leveraging advanced chemical synthesis and formulation technologies, the company delivers a diverse range of therapeutic solutions aimed at addressing unmet medical needs and improving patient health outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于福建广生堂药业股份有限公司申请向特定对象发行股票的第二轮审核问询函的回复 | 2026-03-25 | Chinese | |
| 国浩律师（上海）事务所关于福建广生堂药业股份有限公司2025年度向特定对象发行A股股票之补充法律意见书（七） | 2026-03-25 | Chinese | |
| 关于福建广生堂药业股份有限公司申请向特定对象发行股票的第二轮审核问询函的回复 | 2026-02-10 | Chinese | |
| 关于公司申请向特定对象发行股票的第二轮审核问询函回复的提示性公告 | 2026-02-10 | Chinese | |
| 国浩律师（上海）事务所关于福建广生堂药业股份有限公司2025年度向特定对象发行A股股票之补充法律意见书（六） | 2026-02-10 | Chinese | |
| 北京德皓国际会计师事务所（特殊普通合伙）关于福建广生堂药业股份有限公司申请向特定对象发行股票的审核问询函有关财务事项的说明 | 2026-02-10 | Chinese |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
Fujian Cosunter Pharmaceutical Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55423/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55423 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55423 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55423 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55423}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Fujian Cosunter Pharmaceutical Co., Ltd. (id: 55423)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.